William Phelan
No más puestos en curso
Fortuna: 1 M $ al 30/04/2024
Perfil
William L.
Phelan worked as the Chief Accounting Officer & Senior Vice President at MiMedx Group, Inc. from 2020 to 2023.
Prior to that, he worked as the Chief Accounting Officer & Vice President at Sancilio Pharmaceuticals Co., Inc. Mr. Phelan holds an MBA from The Pennsylvania State University and an undergraduate degree from Shippensburg University of Pennsylvania.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MIMEDX GROUP, INC.
0.12% | 10/05/2023 | 184 219 ( 0.12% ) | 1 M $ | 30/04/2024 |
Antiguos cargos conocidos de William Phelan.
| Empresas | Cargo | Fin |
|---|---|---|
| MIMEDX GROUP, INC. | Comptroller/Controller/Auditor | 01/09/2023 |
Sancilio Pharmaceuticals Co., Inc.
 Sancilio Pharmaceuticals Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio Pharmaceuticals Co. engaged in the development and manufacture of pharmaceutical products. Its product platform, advanced lipid technologies, focuses on the treatment of diseases and disorders related to lipids such as sickle cell, short bowel, severe hypertriglyceridemia and non-alcoholic fatty liver. The company was founded by Frederick Sancilio in October 2004 and was headquartered in Riviera Beach, FL. | Comptroller/Controller/Auditor | - |
Formación de William Phelan.
| Shippensburg University of Pennsylvania | Undergraduate Degree |
| The Pennsylvania State University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MIMEDX GROUP, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Sancilio Pharmaceuticals Co., Inc.
Sancilio Pharmaceuticals Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio Pharmaceuticals Co. engaged in the development and manufacture of pharmaceutical products. Its product platform, advanced lipid technologies, focuses on the treatment of diseases and disorders related to lipids such as sickle cell, short bowel, severe hypertriglyceridemia and non-alcoholic fatty liver. The company was founded by Frederick Sancilio in October 2004 and was headquartered in Riviera Beach, FL. | Commercial Services |
- Bolsa de valores
- Insiders
- William Phelan
